Isabella Testa

机构：Bayer (Italy)

发表论文 55 篇 · 总被引 433 次 · h-index 10

代表论文

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial (2024 · Journal of Clinical Oncology · 被引 170)
Everolimus and Temsirolimus Are Not the Same Second-Line in Metastatic Renal Cell Carcinoma. A Systematic Review and Meta-Analysis of Literature Data (2014 · Clinical Genitourinary Cancer · 被引 34)
Response to Targeted Therapy in Urachal Adenocarcinoma (2014 · Rare Tumors · 被引 25)
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer (2025 · European Urology Oncology · 被引 10)
LBA68 Efficacy and safety of darolutamide plus androgen-deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) from the phase III ARANOTE trial (2024 · Annals of Oncology · 被引 5)
A randomized, controlled, phase 3 study of darolutamide in addition to androgen deprivation therapy (ADT) versus ADT alone in metastatic hormone-sensitive prostate cancer (ARANOTE). (2022 · Journal of Clinical Oncology · 被引 3)